Wingderm® Strengthens Its Presence in North America at the 2025 AAD Annual Meeting
Wingderm® made a significant impression at the 2025 AAD Annual Meeting, an influential event for dermatology professionals held in Orlando, Florida, from March 7 to 9. As a leading player in the aesthetics technology sector, Wingderm® seized the opportunity to highlight its cutting-edge laser technology and innovative devices designed for superior skin treatments.
Innovative Laser Technologies
The standout feature at Wingderm®’s exhibit was its array of advanced laser devices, which are becoming increasingly recognized for their effectiveness in dermatological treatments. The Lasermach series, featuring wavelengths of 755nm, 808nm, and 1064nm, adeptly targets melanin at various follicle depths, ensuring optimal and long-lasting results. Additionally, the 1550nm non-ablative fractional laser is designed to penetrate deep into the skin without harming the epidermis. Using advanced optical scanning technology, it stimulates collagen regeneration, making it a vital tool for skin resurfacing and rejuvenation efforts.
These technologies not only capture the attention of attendees but have also garnered acclaim from dermatological experts across the globe, confirming their safety and effectiveness.
Engaging Demonstrations and Interactions
At the event, Wingderm® engaged several dermatologists and industry enthusiasts through personalized consultations. These sessions tackled essential inquiries related to device performance, maintenance practices, and the specific applications of the laser technologies. Moreover, live demonstrations simulated treatment scenarios, providing a tactile understanding of how these devices operate and their potential benefits, thereby enhancing participants' confidence in their decision to incorporate Wingderm® products into their practices.
Strengthening North American Market Presence
Recognizing the growing demand for its products in the U.S. market, Wingderm® recently established Wingderm USA Inc. in California, aimed at promoting faster response times and improving customer support. This strategic move underscores Wingderm®'s commitment to solidifying its presence in North America.
Carol Ren, CEO of Wingderm USA Inc., stated, “As demand continues to rise for our innovative products, we are committed to showcasing our technologies at more U.S. exhibitions. With ongoing dedication to innovation and brand promotion, we are confident that Wingderm® will further strengthen its position in both the U.S. and global markets.”
A Brief About Wingderm®
Founded in 2016, Wingderm® advocates for the mission
Aesthetics Technology, Easy to Achieve. The company has emerged as a provider of top-tier and reliable intelligent photoelectric medical aesthetic devices, which are now exported to over 80 countries. With more than 15,000 devices installed worldwide, Wingderm® maintains its reputation for safety and efficacy within the aesthetics community.
In conclusion, the participation at the 2025 AAD Annual Meeting not only showcases Wingderm®’s commitment to technological advancement but also sets the stage for its continued growth within the U.S. market, promising exciting developments for clients and practitioners in the dermatology field.
For more information about Wingderm® and its technological innovation, visit
wingderm.com.